Emergence of NDM-4 and OXA-181 carbapenemase-producing Klebsiella pneumoniae

J Glob Antimicrob Resist. 2020 Mar:20:332-333. doi: 10.1016/j.jgar.2020.01.020. Epub 2020 Feb 13.

Authors

Affiliations

¹ Infectious Diseases Team, Seoul Metropolitan Government Research Institute of Public Health and Environment, Gyeonggi-do, Republic of Korea. Electronic address: babygogs@seoul.go.kr.
² Infectious Diseases Team, Seoul Metropolitan Government Research Institute of Public Health and Environment, Gyeonggi-do, Republic of Korea.
³ Sanggye Paik Hospital, Inje University, College of Medicine-Pediatrics, Seoul, Republic of Korea.

PMID: 32061881
DOI: 10.1016/j.jgar.2020.01.020

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged, 80 and over
Bacterial Proteins / genetics*
Colonic Neoplasms / microbiology
Humans
Klebsiella Infections / diagnosis*
Klebsiella Infections / drug therapy
Klebsiella pneumoniae / drug effects
Klebsiella pneumoniae / genetics
Klebsiella pneumoniae / isolation & purification*
Male
Middle Aged
Piperacillin, Tazobactam Drug Combination / therapeutic use
Plasmids / genetics
Rectal Neoplasms / microbiology
Republic of Korea
Treatment Outcome
beta-Lactamases / genetics*

Substances

Bacterial Proteins
Piperacillin, Tazobactam Drug Combination
beta-Lactamases
carbapenemase